Source: Annual Congress 2004 - Immunology of airway and pulmonary disease



Rating:

Share or cite this content

Citations should be made in the following way:
A. B. Kay (London, United Kingdom). Immunoregulation vs remodeling: which is important?. Annual Congress 2004 - Immunology of airway and pulmonary disease

Member's Comments

No comment yet.

Related content which might interest you: Presentation by an expert: Modelling and remodelling: when does asthma begin? Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease Year: 2013 Specific antigen(s) in sarcoidosis: a link to autoimmunity? Source: Eur Respir J 2016; 47: 707-709 Year: 2016 Late Breaking Abstract - Hypoxia-induced responses to mimic ongoing remodelling processes in chronic lung diseases Source: Virtual Congress 2020 – Cellular stress in respiratory diseases Year: 2020 Vascular remodelling in pulmonary hypertension: A role for matrix cross-linking? Source: Annual Congress 2010 - New mechanisms in chronic lung diseases Year: 2010 Regulatory T, B cells and inflammation: Do they play an important role in lung cancer? Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 Lung ageing and COPD: is there a role for ageing in abnormal tissue repair? Source: Eur Respir Rev, 26 (146) 170073; 10.1183/16000617.0073-2017 Year: 2017 Reprogramming of cellular metabolism: driver for airway remodelling in COPD? Source: Eur Respir J, 50 (5) 1702197; 10.1183/13993003.02197-2017 Year: 2017 Location or origin? What is critical for macrophage propagation of lung fibrosis? Source: Eur Respir J, 51 (3) 1800103; 10.1183/13993003.00103-2018 Year: 2018 The role of interleukin-17 in asthma: a protective response? Source: ERJ Open Res, 6 (2) 00364-2019; 10.1183/23120541.00364-2019 Year: 2020 Epithelial barrier dysfunction and remodelling: a link between paediatric and adult asthma Source: International Congress 2014 – Epithelial barrier dysfunction: the link between paediatric and adult respiratory diseases Year: 2014 The GPx1-PTP1B-PP2A axis: A key determinant of airway inflammation and alveolar destruction Source: Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights Year: 2013 Making the case for causality: what role do lung microbiota play in idiopathic pulmonary fibrosis? Source: Eur Respir J, 55 (4) 2000318; 10.1183/13993003.00318-2020 Year: 2020 Bleomycin-induced remodeling – Inflammation and fibrosis are developing in parallel during initiation Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases Year: 2011 Inflammation: friend or foe of muscle remodelling in COPD? Source: Eur Respir J 2007; 30: 605-607 Year: 2007 Platelets: a potential role in chronic respiratory diseases? Source: Eur Respir Rev, 30 (161) 210062; 10.1183/16000617.0062-2021 Year: 2021 Inflammatory cell microlocalisation and airway dysfunction: cause and effect? Source: Eur Respir J 2007; 30: 1043-1056 Year: 2007 Is apoptosis really important? Source: Annual Congress 2012 - Acute lung injury: challenging old paradigms Year: 2012 Asthma and pulmonary arterial hypertension: do they share a key mechanism of pathogenesis? Source: Eur Respir J 2010; 35: 730-734 Year: 2010 Airway remodelling: the future Source: Eur Respir J 2007; 30: 831-834 Year: 2007